{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:38:43Z","timestamp":1779352723237,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.nbd.2008.09.021","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T05:27:34Z","timestamp":1224134854000},"page":"96-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy"],"prefix":"10.1016","volume":"33","author":[{"given":"Antje","family":"Kroner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Wang","family":"Ip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Wessig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2008.09.021_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/glia.20386","article-title":"Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot\u2013Marie\u2013Tooth disease)","volume":"54","author":"Berger","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2008.09.021_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1083\/jcb.152.2.301","article-title":"The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0","volume":"152","author":"Carenini","year":"2001","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.nbd.2008.09.021_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2006.10.006","article-title":"PD-1\/PD-L1, but not PD-1\/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Carter","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2008.09.021_bib5","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1084\/jem.20061577","article-title":"Insulin-induced remission in new-onset NOD mice is maintained by the PD-1\u2013PD-L1 pathway","volume":"203","author":"Fife","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2008.09.021_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.mcn.2007.10.012","article-title":"Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy","volume":"37","author":"Fischer","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2008.09.021_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0092-8674(92)90591-Y","article-title":"Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons","volume":"71","author":"Giese","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2008.09.021_bib8","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1161\/CIRCULATIONAHA.107.709360","article-title":"Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart","volume":"116","author":"Grabie","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.nbd.2008.09.021_bib9","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1523\/JNEUROSCI.1921-06.2006","article-title":"Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes","volume":"26","author":"Ip","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.09.021_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1385\/NMM:8:1-2:175","article-title":"Role of immune cells in animal models for inherited peripheral neuropathies","volume":"8","author":"Ip","year":"2006","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.nbd.2008.09.021_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nbd.2006.08.023","article-title":"Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice","volume":"25","author":"Ip","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2008.09.021_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance","volume":"203","author":"Keir","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2008.09.021_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/brain\/awg072","article-title":"Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1","volume":"126","author":"Kobsar","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2008.09.021_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.humimm.2007.01.012","article-title":"The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis","volume":"68","author":"Kroner","year":"2007","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/exnr.1993.1017","article-title":"Methods to assess the development and recovery of locomotor function after spinal cord injury in rats","volume":"119","author":"Kunkel-Bagden","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2008.09.021_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.mcn.2007.08.002","article-title":"Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice","volume":"36","author":"Leder","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2008.09.021_bib18","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib19","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1523\/JNEUROSCI.4794-04.2005","article-title":"Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS","volume":"25","author":"Magnus","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.09.021_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1474-4422(04)00822-1","article-title":"Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients","volume":"3","author":"Martini","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2008.09.021_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ng1195-281","article-title":"Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies","volume":"11","author":"Martini","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2008.09.021_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1006\/mcne.2001.0990","article-title":"Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants","volume":"17","author":"Maurer","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2008.09.021_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1385\/NMM:8:1-2:217","article-title":"Pathomechanisms of mutant proteins in Charcot\u2013Marie\u2013Tooth disease","volume":"8","author":"Niemann","year":"2006","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.nbd.2008.09.021_bib24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/intimm\/10.10.1563","article-title":"Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses","volume":"10","author":"Nishimura","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","article-title":"The PD-1\u2013PD-L pathway in immunological tolerance","volume":"27","author":"Okazaki","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int. Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0952-7915(02)00398-9","article-title":"New regulatory co-receptors: inducible co-stimulator and PD-1","volume":"14","author":"Okazaki","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib28","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/eji.200738071","article-title":"B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis","volume":"38","author":"Ortler","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuron.2007.12.021","article-title":"Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot\u2013Marie\u2013Tooth 1B mice","volume":"57","author":"Pennuto","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2008.09.021_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20022119","article-title":"Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis","volume":"198","author":"Salama","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2008.09.021_bib31","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1523\/JNEUROSCI.23-07-02833.2003","article-title":"The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy","volume":"23","author":"Samsam","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.09.021_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1523\/JNEUROSCI.20-02-00729.2000","article-title":"Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance","volume":"20","author":"Schmid","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.09.021_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1443","article-title":"The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection","volume":"8","author":"Sharpe","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2008.09.021_bib34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00005072-199756070-00008","article-title":"Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"56","author":"Shy","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2008.09.021_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jnr.20873","article-title":"Heterozygous P0 deficiency protects mice from vincristine-induced polyneuropathy","volume":"84","author":"Uceyler","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2008.09.021_bib36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/(SICI)1097-4598(199608)19:8<946::AID-MUS2>3.0.CO;2-8","article-title":"Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations","volume":"19","author":"Zielasek","year":"1996","journal-title":"Muscle Nerve"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108002301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108002301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:03:01Z","timestamp":1760850181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108002301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0969996108002301"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.09.021","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2008.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}